Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gold Bond extensions

This article was originally published in The Tan Sheet

Executive Summary

TV ads for Antifungal Swabs, indicated for treatment of athlete's foot, will break in May with 30-second spots, dropping to 15-second after product introduction, Chattem says. Swabs contain tolnaftate 1%, employ "hands free" swab delivery system (1"The Tan Sheet" Sept. 30, 2002, p. 5). Similar ad schedule is planned for new First Aid Antiseptic Wipes, First Aid Antiseptic Quick Spray, which contain benzethonium chloride .13%, menthol 1%. Gold Bond extensions are reaching shelves now...

You may also be interested in...

Chattem Gold Bond Bolstered With Three New Products Shipping In 2003

Chattem is hoping three new Gold Bond line extensions - two in the first aid treatment category and one for athlete's foot - will drive double-digit growth in the brand in 2003

QUOTED. 19 February 2020. Stephen Hahn.

The US FDA has abandoned all near-term plans to inspect Chinese manufacturing facilities in the wake of the coronavirus crisis. See what agency head Stephen Hahn said about it here.

DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss

The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts